Drug Search Results
Using advanced filters...
Advanced Search [+]

Ilaprazole

Alternative Names: ilaprazole, noltec
Latest Update: 2024-12-10
Latest Update Note: Clinical Trial Update

Product Description

Il-Yang Pharm is developing Ilaprazole as a treatment for acid-related diseases. (Sourced from: https://www.ilyang.co.kr/english/rnd/rnd03.asp)

Mechanisms of Action: Proton Pump Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: China | Ecuador | India | Indonesia | Korea | Mexico | Turkey

Approved Indications: None

Known Adverse Events: None

Company: Il-Yang Pharm
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Ilaprazole

Countries in Clinic: China, Korea

Active Clinical Trial Count: 4

Highest Development Phases

Phase 3: Generalized anxiety disorder|Injuries/wounds Unspecified|Peptic Ulcer

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

IY-NTNS03

P3

Not yet recruiting

Peptic Ulcer

2026-08-30

33%

IY-NS250SB

P1

Completed

Healthy Volunteers

2024-04-13

CTR20210784

P3

Not yet recruiting

Generalized anxiety disorder|Injuries/wounds Unspecified

None

CTR20133004

P2

Recruiting

Peptic Ulcer

None

Recent News Events